Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Biochem Q1 Revenues Up 5 Percent

NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Thursday that its fiscal 2018 first quarter revenues rose 5 percent year over year, thanks largely to a 10 percent increase in revenues from its clinical labs business.

For the three months ended Oct. 31, the molecular diagnostics company reported total revenues of $27.7 million, up from $26.3 million in Q1 2017.

Revenues from the clinical labs business rose to $20.3 million from $18.6 million in the prior-year period, offsetting a 4 percent dip in product revenues to $7.1 million from $7.4 million year over year. Royalty and license fee income also fell 13 percent to $261,000 from $300,000.

"The first quarter of fiscal 2018 saw additional progress in moving aggressively towards our model as an integrated, growth-oriented molecular diagnostics company, and a low-cost medically related assay provider and reference service organization," Enzo President Barry Weiner said in a statement. He noted that the growth in clinical labs revenues was the result of expanded product and service capabilities, as well as geographical expansion, "along with increasing volume from our association with leading healthcare insurance providers." 

Enzo's Q1 net loss narrowed to $640,000, or $.01 per share, from $1.5 million, or $.03 per share, a year earlier.

The firm's R&D expenses for the quarter fell 9 percent to $747,000 from $822,000 a year ago, and its Q1 SG&A costs dipped 6 percent to $10.8 million from $11.5 million in Q1 2017.

Enzo ended the quarter with $66.8 million in cash and cash equivalents.

Weiner said that the company is preparing to release a 13-analyte women's health diagnostics panel, which it presented last month at the annual meeting of the Association for Molecular Pathology. "Our focus is on gaining sustained profitability and advancing healthcare in today's challenging environment by providing affordable and reliable diagnostic testing," he added. "[Enzo's] expanding line of medically related, versatile, highly efficient platforms and assays … are increasingly professionally recognized for their sensitivity and economics."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.